Neutralizing human monoclonal antibodies against hiv-1, their production and uses
CA 2436091 A1 · Owner: Corvalan, Jose R. · Inventors: Pinter, Abraham; Corvalan, Jose R.; He, Yuxian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a novel human antibody and antigen-binding , portion thereof, that specifically binds HIV-1 gp120 protein and that has HIV- 1- neutralizing activity. The present invention also relates to a cell line that produces an antibody of this invention. The present invention further relates to a pharmaceutical composition or a kit comprising an antibody or antigen binding portion thereof of this invention. The present invention further relates to a method of using the antibody of this invention to treat a subject with an HIV-1 infection or prevent a subject from getting an HIV-1 infection. The present invention also relates to a novel method of making an …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 25, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 25, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 25, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.